Melagatran is a direct thrombin inhibitor used as an anticoagulant to prevent venous thromboembolism in patients undergoing orthopedic surgeries such as hip or knee replacement. This medication functions… Read more
Melagatran is a direct thrombin inhibitor used as an anticoagulant to prevent venous thromboembolism in patients undergoing orthopedic surgeries such as hip or knee replacement. This medication functions by directly binding to thrombin, thereby preventing the conversion of fibrinogen to fibrin. The Melagatran product category encompasses high-quality reference standards, including the active pharmaceutical ingredient, deuterated internal standards such as Melagatran-d11 and Ximelagatran-d11, and significant metabolites like N-Hydroxy Melagatran-d11. These compounds are essential tools for pharmaceutical laboratories performing impurity profiling, method validation, and rigorous quality control. By utilizing stable isotope labelled compounds and precise reference materials, researchers can ensure accurate quantification and characterization of the drug and its related substances throughout the drug development and manufacturing lifecycle, supporting compliance with established regulatory analytical standards.